Objective: A high mortality rate occurs with silent myocardial infarction (MI), particularlyin aging and diabetic populations due to defects in the transient receptor potential vanilloid (TRPV1)-positive sensory nerve function. We have previously shown that TRPV1 deficiency markedly enhances post-MI inflammation and remodeling. However, the mechanisms remain unknown. The objective of this study was to clarify whether calcitonin gene-related peptide (CGRP) release was associated with the protective role of TRPV1 against postmyocardial inflammation and apoptosis. Methods: TRPV1 gene knockout (TRPV1KO) and wild-type (WT) mice were subjected to left anterior descending ligation or sham operation. The concentration of CGRP in the myocardium was measured at 30 min, 1, 6 and 24 h post-MI. Mice received saline vehicle, CGRP or the CGRP antagonist CGRP8-37 before ligation. Inflammation was evaluated by ELISA assay and histological staining. Apoptosis was assessed by Western blot and TUNEL assay. Results: Post-MI, both TRPV1KO and WT mice displayed elevated CGRP levels in myocardium when compared to sham controls. However, the levels of CGRP were significantly lower in TRPV1KO mice than in WT mice at 30 min after MI. Exogenous CGRP downregulated the levels of tumor necrosis factor-α and interleukin-6 expression in TRPV1KO mice post-MI. Moreover, exogenous CGRP decreased the neutrophil infiltration in TRPV1KO mice, whereas inhibition of CGRP by CGRP8-37 increased the neutrophil infiltration in WT mice. Western blotting data indicated that CGRP attenuated caspase-3 and caspase-9 expression, and enhanced Bcl-2 expression in TRPV1KO mice post-MI. CGRP8-37 upregulated caspase-3 and caspase-9 expression and downregulated Bcl-2 expression in WT mice. Conclusion: Our data suggest a protective role of TRPV1 activation against inflammation and apoptosis in mice post-MI, possibly through CGRP release. These findings elucidate a neurogenic mechanism in mice post-MI, which may participate in sensory neurotransmitter-mediated protection in TRPV1 activation.
Sensitive detection of small molecules is crucial for
many applications,
like biomedical diagnosis, food safety, and environmental analysis.
Here, we describe a sensitive CRISPR-Cas12a-assisted immunoassay for
small molecule detection in homogeneous solution. An active DNA (acDNA)
modified with a specific small molecule serves as a competitor for
antibody binding and an activator of CRISPR-Cas12a. Large-sized antibody
binding with this acDNA probe inactivates the collateral cleavage
activity of CRISPR-Cas12a due to a steric effect. When free small
molecule target exists, it replaces the small molecule-modified acDNA
from antibody, triggering catalytic cleavage of DNA reporters by CRISPR-Cas12a,
and strong fluorescence is generated. With this strategy, we achieved
detection of three important small molecules as models, biotin, digoxin,
and folic acid, at picomolar levels by using streptavidin or antibody
as recognition elements. With the progress of DNA-encoded small molecules
and antibody, the proposed strategy provides a powerful toolbox for
detection of small molecules in wide applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.